Active Ingredients (In Each Tablet)
Pseudoephedrine HCl 60 mg
Triprolidine HCl 2.5 mg
The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Aprodine (NDC 0904-7302). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Pseudoephedrine HCl 60 mg
Triprolidine HCl 2.5 mg
Nasal decongestant
Antihistamine
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
taking sedatives or tranquilizers.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
hypromellose, magnesium stearate, polyethylene glycol, silicified microcrystalline cellulose, titanium dioxide
1-800-426-9391
MAJOR®
NDC 0904-7302-60
maximum strength
Aprodine™ tablets
pseudoephedrine HCl 60 mg
nasal decongestant
triprolidine HCl 2.5 mg
antihistamine
FOR PHARMACY USE ONLY.
NOT FOR RETAIL SALE.
relieves: • nasal congestion • sneezing • runny nose • itchy, watery eyes
actual size
100 tablets
* Please review the disclaimer below.